Two or more headaches in a week warrant a doctor's visit

Cambridge scientists have created a breakthrough material that can sense tiny chemical changes in the body, such as the increased acidity during an arthritis flare-up, and release drugs exactly when and where they're needed.

The Researchers at the University of California San Diego School of Medicine have identified a new investigational drug that shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease linked to obesity and type 2 diabetes that can lead to cirrhosis, liver failure, and even liver cancer.

A groundbreaking wireless implant promises real-time, personalised pain relief using AI and ultrasound power, no batteries, no wires, and no opioids. Designed by University of Southern California (USC) and University of California, Los Angeles (UCLA) engineers, it reads brain signals, adapts on the fly, and bends naturally with your spine.

Researchers have created a revolutionary robotic skin that brings machines closer to human-like touch.

New research has found that those who consume a diverse range of foods rich in flavonoids, such as tea, berries, dark chocolate, and apples, could lower their risk of developing serious health conditions and have the potential to live longer.

A study shows a non-opioid pain reliever blocks pain at its source -- calming specific nerve signals that send pain messages to the brain. In mice, the compound SBI-810 eased pain from surgery, bone fractures, and nerve injury without causing sedation or constipation.

People with excess weight are more likely to experience long-term neurological and mental health symptoms after Covid-19, including headache, vertigo, smell and taste disorders, sleep disturbance, and depression.

Researchers used visual threat manipulation in the virtual reality environment and thermal stimulation to investigate how the brain perceives pain. They found that the brain perceives pain more strongly when the perceived pain is out of alignment with reality. In particular, pain was amplified when unexpected events occurred.

People receiving haemodialysis for kidney failure frequently feel chronic pain associated with their disease, which can be difficult to manage with opioid medication and other traditional treatments.

Researchers at the University of Colorado Anschutz Medical Campus found a promising therapeutic candidate that could aid in the restoration of vision in those suffering from multiple sclerosis (MS) and other neurodegenerative diseases.